Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Novo Nordisk’s new Ozempic ads star Justin Long and John Hodgman, the “Mac” and “PC” of an iconic Apple campaign, to promote ...

Gene therapy for weight loss is being explored as a potential game-changer, with therapy aiming to program the body to ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

GLP-1 medication scams are rising fast. Learn how fake pharmacies, ads, and messages work — and how to spot them early.

The actress opened up to PEOPLE about her “miraculous” weight loss ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar ...

Sally Lyons Wyatt, from Data analytics company Circana, says GLP-1 potential users are only three percent more likely to buy ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...